
Falcina Injection (60 mg)
Falcina Injection contains Artesunate 60 mg, an antimalarial medication used for the treatment of severe malaria, especially caused by Plasmodium falciparum.
Falcina Injection (60 mg) is a fast-acting antimalarial injectable formulation containing Artesunate, primarily indicated for the treatment of severe malaria, particularly when oral therapy is not feasible. It works by rapidly killing the malaria parasite in the blood, helping to control high parasitemia and life-threatening symptoms. Recommended by WHO for emergency treatment, Falcina Injection is often used in hospital settings to stabilize the patient before switching to oral medication. It is especially useful in cases of cerebral malaria and drug-resistant strains.
๐ Uses
Treatment of severe malaria
Used in hospital emergency settings
Effective against Plasmodium falciparum
๐ก Benefits
Rapid reduction of malaria parasites
Suitable for unconscious or vomiting patients
Life-saving treatment in critical malaria cases
WHO-recommended therapy
โ ๏ธ Side Effects
Temporary injection site pain
Dizziness
Low white blood cell count (rare)
Nausea or fever
Allergic reactions (rare)
๐ How to Use
Administered intravenously or intramuscularly under medical supervision
Dosage based on body weight and severity
Should be followed by a full course of oral antimalarial therapy
For hospital/institutional use only
โ๏ธ Safety Advice
To be used under strict medical supervision
Not for self-administration
Safe for use during pregnancy (second and third trimesters)
Monitor for allergic reactions or unusual symptoms
Store in a cool, dry place, away from sunlight